{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:13:05Z","timestamp":1790291585612,"version":"4.1.0"},"reference-count":44,"publisher":"American Diabetes Association","issue":"suppl_3","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,12,1]]},"abstract":"<jats:p>In nondiabetic subjects, obesity is associated with a modest expansion of \u03b2-cell mass, possibly amounting\u2014according to the best available estimates\u2014to 10\u201330% for each 10 kg of weight excess. Whether age of onset and duration of obesity, recent changes in body weight, and body fat distribution have any effect on \u03b2-cell mass in humans is unknown. Both fasting insulin secretion and the total insulin response to oral glucose have the following characteristics: 1) they increase with BMI in an approximately linear fashion, 2) both fat-free and fat mass are significant positive correlates, and 3) BMI exerts a positive effect separate from that of insulin resistance (i.e., obesity may be a state of primary insulin hypersecretion). The mechanisms are currently unknown, though chronic small increments in plasma glucose may play a role. In contrast, dynamic properties of \u03b2-cell function, such as glucose sensitivity (i.e., dose-response function), rate sensitivity, and potentiation, do not appear to be substantially altered by the presence of obesity, body fat distribution, or insulin resistance as long as glucose tolerance is maintained. Weight loss, by diet or restrictive bariatric surgery, is associated with consensual decrements in insulin resistance and insulin hypersecretion. The latter, however, seems to be more persistent, suggesting that the postobese state may reproduce the primary insulin hypersecretion of the obese state. Malabsorptive bariatric surgery, in contrast, normalizes insulin sensitivity and abolishes insulin hypersecretion even before achievement of ideal body weight. Lipid-triggered messages from the gastrointestinal tract to the insulin target tissues and endocrine pancreas are the subject of intense investigation.<\/jats:p>","DOI":"10.2337\/diabetes.53.suppl_3.s26","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"S26-S33","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":119,"title":["Beta-Cell Function in Obesity"],"prefix":"10.2337","volume":"53","author":[{"given":"Ele","family":"Ferrannini","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and CNR Institute of Clinical Physiology, University of Pisa School of Medicine, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Camastra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and CNR Institute of Clinical Physiology, University of Pisa School of Medicine, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Gastaldelli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and CNR Institute of Clinical Physiology, University of Pisa School of Medicine, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maira","family":"Sironi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and CNR Institute of Clinical Physiology, University of Pisa School of Medicine, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Natali","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and CNR Institute of Clinical Physiology, University of Pisa School of Medicine, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elza","family":"Muscelli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and CNR Institute of Clinical Physiology, University of Pisa School of Medicine, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geltrude","family":"Mingrone","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Catholic University, School of Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[{"name":"CNR Institute of Biomedical Engineering, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031209074082800_R1","doi-asserted-by":"crossref","unstructured":"Rabinowitz D, Zierler KL: Forearm metabolism in obesity and its response to intra-arterial insulin: characterization of insulin resistance and evidence for adaptive hyperinsulinism. J Clin Invest\u200841:2173\u20132181,1962","DOI":"10.1172\/JCI104676"},{"key":"2022031209074082800_R2","doi-asserted-by":"crossref","unstructured":"Montanya E, Nacher V, Biarne\u0301s M, Soler J: Linear correlation between \u03b2-cell mass and body weight throughout the lifespan in Lewis rats: role of \u03b2-cell hyperplasia and hypertrophy. Diabetes\u200849:1341\u20131346,2000","DOI":"10.2337\/diabetes.49.8.1341"},{"key":"2022031209074082800_R3","doi-asserted-by":"crossref","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: \u03b2-cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes. Diabetes\u200852:102\u2013110,2003","DOI":"10.2337\/diabetes.52.1.102"},{"key":"2022031209074082800_R4","doi-asserted-by":"crossref","unstructured":"Curry DL, Safarik RH, Reaven E: Effect of age on the insulin secretory response of perfused rat pancreas to arginine and tolbutamide. Horm Metab Res\u200819:453\u2013457,1987","DOI":"10.1055\/s-2007-1011852"},{"key":"2022031209074082800_R5","doi-asserted-by":"crossref","unstructured":"Iozzo P, Beck-Nielsen H, Laakso M, Smith U, Yki-Jarvinen H, Ferrannini E: Independent influence of age on basal insulin secretion in nondiabetic humans: European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab\u200884:863\u2013868,1999","DOI":"10.1210\/jcem.84.3.5542"},{"key":"2022031209074082800_R6","doi-asserted-by":"crossref","unstructured":"Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, Yoo SJ, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim HS, Lee IK, Bonner-Weir S: Selective \u03b2-cell loss and \u03b2-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab\u200888:2300\u20132308,2003","DOI":"10.1210\/jc.2002-020735"},{"key":"2022031209074082800_R7","unstructured":"Kahn SE, Porte D Jr: The pathophysiology of type II (noninsulin-dependent) diabetes mellitus: implications for treatment. In Ellenberg and Rifkin\u2019s Diabetes Mellitus: Theory and Practice. 5th ed. Porte D, Jr, Sherwin RS, Eds. Stamford, Appleton & Lange,1997, p.487\u2013512"},{"key":"2022031209074082800_R8","doi-asserted-by":"crossref","unstructured":"Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, Gingerich R, Goldstein D, Widemeyer HM, Haffner S, Hales CN, Jarett L, Polonsky K, Porte D, Skyler J, Webb G, Gallagher K: Report of the American Diabetes Association\u2019s Task Force on standardization of the insulin assay. Diabetes\u200845:242\u2013256,1996","DOI":"10.2337\/diabetes.45.2.242"},{"key":"2022031209074082800_R9","doi-asserted-by":"crossref","unstructured":"Ferrannini E, Cobelli C: The kinetics of insulin in man. I. General aspects. Diabete Metab Rev\u20083:335\u2013363,1987","DOI":"10.1002\/dmr.5610030201"},{"key":"2022031209074082800_R10","doi-asserted-by":"crossref","unstructured":"Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance and hypersecretion in obesity. J Clin Invest\u2008100:1166\u20131173,1997","DOI":"10.1172\/JCI119628"},{"key":"2022031209074082800_R11","doi-asserted-by":"crossref","unstructured":"Ferrannini E, Cobelli C: The kinetics of insulin in man. II. Role of the liver. Diabete Metab Rev\u20083:365\u2013397,1987","DOI":"10.1002\/dmr.5610030202"},{"key":"2022031209074082800_R12","doi-asserted-by":"crossref","unstructured":"Clark JM, Brancati FL, Diehl AM: The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol\u200898:960\u2013967,2003","DOI":"10.1111\/j.1572-0241.2003.07486.x"},{"key":"2022031209074082800_R13","doi-asserted-by":"crossref","unstructured":"Clark JM, Diehl AM: Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA\u2008289:3000\u20133004,2003","DOI":"10.1001\/jama.289.22.3000"},{"key":"2022031209074082800_R14","doi-asserted-by":"crossref","unstructured":"Ferrannini E, Mari A: Beta cell function and its relation to insulin action in man: a critical appraisal. Diabetologia\u200847:343\u2013356,2004","DOI":"10.1007\/s00125-004-1381-z"},{"key":"2022031209074082800_R15","doi-asserted-by":"crossref","unstructured":"Ferrannini E, Pilo A: Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance. J Clin Invest\u200864:243\u2013254,1979","DOI":"10.1172\/JCI109445"},{"key":"2022031209074082800_R16","doi-asserted-by":"crossref","unstructured":"Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J: Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab\u200851:520\u2013528,1980","DOI":"10.1210\/jcem-51-3-520"},{"key":"2022031209074082800_R17","doi-asserted-by":"crossref","unstructured":"Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes\u200841:368\u2013377,1992","DOI":"10.2337\/diabetes.41.3.368"},{"key":"2022031209074082800_R18","doi-asserted-by":"crossref","unstructured":"Muscelli E, Camastra S, Catalano C, Quin\u0303ones Galvan A, Ciociaro D, Baldi S, Ferrannini E: Metabolic and cardiovascular assessment in moderate obesity: effect of weight loss. J Clin Endocrinol Metab\u200882:2937\u20132943,1997","DOI":"10.1210\/jcem.82.9.4228"},{"key":"2022031209074082800_R19","doi-asserted-by":"crossref","unstructured":"Ferrannini E, Camastra S, Coppack SW, Fliser D, Golay A, Mitrakou A: Insulin action and non-esterified fatty acids. Proc Nutr Soc\u200856:753\u2013761,1997","DOI":"10.1079\/PNS19970076"},{"key":"2022031209074082800_R20","doi-asserted-by":"crossref","unstructured":"Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, Camastra S, Ferrannini E: Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes\u200851:144\u2013151,2002","DOI":"10.2337\/diabetes.51.1.144"},{"key":"2022031209074082800_R21","doi-asserted-by":"crossref","unstructured":"Grodsky GM: A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. J Clin Invest\u200851:2047\u20132059,1972","DOI":"10.1172\/JCI107011"},{"key":"2022031209074082800_R22","doi-asserted-by":"crossref","unstructured":"Henquin JC, Ishiyama N, Nenquin M, Ravier MA, Jonas JC: Signals and pools underlying biphasic insulin secretion. Diabetes\u200851 (Suppl. 1):S60\u2013S67,2002","DOI":"10.2337\/diabetes.51.2007.S60"},{"key":"2022031209074082800_R23","doi-asserted-by":"crossref","unstructured":"Bergman RN, Urquhart J: The pilot gland approach to the study of insulin secretory dynamics. Recent Prog Horm Res\u200827:583\u2013605,1971","DOI":"10.1016\/B978-0-12-571127-2.50039-0"},{"key":"2022031209074082800_R24","doi-asserted-by":"crossref","unstructured":"Licko V: Threshold secretory mechanism: a model of derivative element in biological control. Bull Math Biol\u200835:51\u201358,1973","DOI":"10.1016\/S0092-8240(73)80007-2"},{"key":"2022031209074082800_R25","doi-asserted-by":"crossref","unstructured":"Cerasi E, Fick G, Rudemo M: A mathematical model for the glucose induced insulin release in man. Eur J Clin Invest\u20084:267\u2013278,1974","DOI":"10.1111\/j.1365-2362.1974.tb00403.x"},{"key":"2022031209074082800_R26","doi-asserted-by":"crossref","unstructured":"Nesher R, Cerasi E: Biphasic insulin release as the expression of combined inhibitory and potentiating effects of glucose. Endocrinology\u2008121:1017\u20131024,1987","DOI":"10.1210\/endo-121-3-1017"},{"key":"2022031209074082800_R27","unstructured":"Cerasi E: Differential actions of glucose on insulin release: re-evaluation of a mathematical model. In Carbohydrate Metabolism Quantitative Physiology and Mathematical Modelling. Cobelli C, Bergman RN, Eds. Chichester, Wiley,1981, p.3\u201322"},{"key":"2022031209074082800_R28","doi-asserted-by":"crossref","unstructured":"Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C: Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes\u200850:150\u2013158,2001","DOI":"10.2337\/diabetes.50.1.150"},{"key":"2022031209074082800_R29","doi-asserted-by":"crossref","unstructured":"Cretti A, Lehtovirta M, Bonora E, Brunato B, Zenti MG, Tosi F, Caputo M, Caruso B, Groop LC, Muggeo M, Bonadonna RC: Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest\u200831:405\u2013416,2001","DOI":"10.1046\/j.1365-2362.2001.00827.x"},{"key":"2022031209074082800_R30","doi-asserted-by":"crossref","unstructured":"Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E: Meal and oral glucose tests for the assessment of \u03b2-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab\u2008283:E1159\u2013E1166,2002","DOI":"10.1152\/ajpendo.00093.2002"},{"key":"2022031209074082800_R31","doi-asserted-by":"crossref","unstructured":"Mari A, Tura A, Gastaldelli A, Ferrannini E: Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes\u200851 (Suppl. 1):S221\u2013S226,2002","DOI":"10.2337\/diabetes.51.2007.S221"},{"key":"2022031209074082800_R32","doi-asserted-by":"crossref","unstructured":"Weyer C, Hanson K, Bogardus C, Pratley RE: Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight. Diabetologia\u200843:36\u201346,2000","DOI":"10.1007\/s001250050005"},{"key":"2022031209074082800_R33","doi-asserted-by":"crossref","unstructured":"Holte J, Bergh T, Berne C, Wide L, Lithell H: Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab\u200880:2586\u20132593,1995","DOI":"10.1210\/jcem.80.9.7673399"},{"key":"2022031209074082800_R34","doi-asserted-by":"crossref","unstructured":"Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A: Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. J Clin Endocrinol Metab\u200864:661\u2013668,1987","DOI":"10.1210\/jcem-64-4-661"},{"key":"2022031209074082800_R35","doi-asserted-by":"crossref","unstructured":"Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr: Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes\u200842:1663\u20131672,1993","DOI":"10.2337\/diabetes.42.11.1663"},{"key":"2022031209074082800_R36","doi-asserted-by":"crossref","unstructured":"Guldstrand M, Ahre\u0301n B, Adamson U: Improved \u03b2-cell function after standardized weight loss in severely obese subjects. Am J Physiol Endocrinol Metab\u2008284:E557\u2013E565,2003","DOI":"10.1152\/ajpendo.00325.2002"},{"key":"2022031209074082800_R37","doi-asserted-by":"crossref","unstructured":"Swinburn BA, Nyomba BL, Saad MF, Zurlo F, Raz I, Knowler WC, Lillioja S, Bogardus C, Ravussin E: Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest\u200888:168\u2013173,1991","DOI":"10.1172\/JCI115274"},{"key":"2022031209074082800_R38","unstructured":"Valdez R, Mitchell BD, Haffner SM, Hazuda HP, Morales PA, Monterrosa A, Stern MP: Predictors of weight change in a bi-ethnic population: the San Antonio Heart Study. Int J Obes Relat Metab Disord\u200818:85\u201391,1994"},{"key":"2022031209074082800_R39","doi-asserted-by":"crossref","unstructured":"Campfield LA, Smith FJ, Mackie G, Tenenbaum R, Sassano ML, Mullin J, Kaiser K, Kierstead RW: Insulin normalization as an approach to the pharmacological treatment of obesity. Obes Res\u20083 (Suppl. 4):591S\u2013603S,1995","DOI":"10.1002\/j.1550-8528.1995.tb00231.x"},{"key":"2022031209074082800_R40","doi-asserted-by":"crossref","unstructured":"Kelley DE, Wing R, Buonocore C, Sturis J, Polonsky K, Fitzsimmons M: Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab\u200877:1287\u20131293,1993","DOI":"10.1210\/jcem.77.5.8077323"},{"key":"2022031209074082800_R41","doi-asserted-by":"crossref","unstructured":"Robertson RP, Harmon J, Tran PO, Poitout V: Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes\u200853 (Suppl. 1):S119\u2013S124,2004","DOI":"10.2337\/diabetes.53.2007.S119"},{"key":"2022031209074082800_R42","doi-asserted-by":"crossref","unstructured":"Ilkova H, Glaser B, Tunckale A, Bagriacik N, Cerasi E: Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care\u200820:1353\u20131356,1997","DOI":"10.2337\/diacare.20.9.1353"},{"key":"2022031209074082800_R43","unstructured":"Valensi P, Moura I, Le Magoarou M, Paries J, Perret G, Attali JR: Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment. Diabete Metab\u200823:515\u2013517,1997"},{"key":"2022031209074082800_R44","unstructured":"Fery F, Melot C, Bosson D, Balasse EO: Effect of short term fasting on glucose tolerance and insulin secretion: influence of the initial glucose level. Diabete Metab\u200816:77\u201385,1990"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/53\/suppl_3\/S26\/379964\/zdb11204000s26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/53\/suppl_3\/S26\/379964\/zdb11204000s26.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:23:34Z","timestamp":1667406214000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/53\/suppl_3\/S26\/13884\/Beta-Cell-Function-in-ObesityEffects-of-Weight"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,1]]},"references-count":44,"journal-issue":{"issue":"suppl_3","published-print":{"date-parts":[[2004,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.53.suppl_3.s26","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,1]]}}}